Claritev (NYSE:CTEV – Get Free Report) is one of 93 publicly-traded companies in the “Healthcare Technology” industry, but how does it compare to its peers? We will compare Claritev to related businesses based on the strength of its institutional ownership, valuation, profitability, earnings, analyst recommendations, dividends and risk.
Risk and Volatility
Claritev has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500. Comparatively, Claritev’s peers have a beta of 1.11, suggesting that their average share price is 11% more volatile than the S&P 500.
Analyst Ratings
This is a summary of recent ratings and price targets for Claritev and its peers, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Claritev | 1 | 2 | 6 | 0 | 2.56 |
| Claritev Competitors | 457 | 1542 | 2763 | 90 | 2.51 |
Valuation & Earnings
This table compares Claritev and its peers top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Claritev | $965.41 million | -$284.28 million | -1.12 |
| Claritev Competitors | $342.79 million | -$24.15 million | 11.30 |
Claritev has higher revenue, but lower earnings than its peers. Claritev is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Profitability
This table compares Claritev and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Claritev | -27.05% | N/A | -5.74% |
| Claritev Competitors | -749.77% | -27.84% | -15.02% |
Institutional and Insider Ownership
87.2% of Claritev shares are held by institutional investors. Comparatively, 42.4% of shares of all “Healthcare Technology” companies are held by institutional investors. 7.4% of Claritev shares are held by company insiders. Comparatively, 16.2% of shares of all “Healthcare Technology” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Summary
Claritev beats its peers on 8 of the 13 factors compared.
About Claritev
Claritev, formerly known as MultiPlan, provides technology-enabled services intended to help manage healthcare costs and support payment accuracy. Its offerings include access to provider networks, claims and payment solutions, and data analytics for evaluating healthcare costs and utilization. The company serves health plans, self-insured employers, third-party administrators and other participants in the U.S. healthcare system. Its services are designed to help customers identify cost-management opportunities and support more efficient healthcare transactions.
Receive News & Ratings for Claritev Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Claritev and related companies with MarketBeat.com's FREE daily email newsletter.
